An eyecare foundation model for clinical assistance: a randomized controlled trial

IF 50 1区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
Yilan Wu, Bo Qian, Tingyao Li, Yiming Qin, Zhouyu Guan, Tingli Chen, Yali Jia, Ping Zhang, Dian Zeng, Sayoko Moroi, Rajiv Raman, Benjamin Sommer Thinggaard, Frederik Pedersen, José Alogo Obiang Ñehe, Tengku Ain Kamalden, Yukun Zhou, Yixiao Jin, Huating Li, An Ran Ran, Dawei Yang, Ziyao Meng, Qingsheng Peng, Ying Feng Zheng, Dingqiao Wang, Hongwei Ji, Pengxiao Zang, Changchang Yin, Jie Shen, Youxin Chen, Weihong Yu, Rongping Dai, Chenxi Zhang, Xinyu Zhao, Xiangning Wang, Yan Chen, Qiang Wu, Hongbin Xie, Simon K. H. Szeto, Julia Y. Y. Chan, Victor T. T. Chan, Hua-Tao Xie, Ruili Wei, Jin Li, Weizhi Ma, Lei Zhu, Hongqiu Wang, Huazhu Fu, Wenxiao Wang, Shan Lin, Zejun Xu, Nian Guan, Xiao Zhang, Andrzej Grzybowski, Monika Gołębiowska-Bogaj, Maciej Gawęcki, Adrian Smedowski, Wojciech Szaraniec, You Wu, Yang Wen, Xiang Chen, Yuanqi Yao, Lee-Ling Lim, Carol Y. Cheung, Gavin Siew Wei Tan, Jakob Grauslund, Paisan Ruamviboonsuk, Sobha Sivaprasad, Pearse A. Keane, Ya Xing Wang, Yih-Chung Tham, Ching-Yu Cheng, Tien Yin Wong, Bin Sheng
{"title":"An eyecare foundation model for clinical assistance: a randomized controlled trial","authors":"Yilan Wu, Bo Qian, Tingyao Li, Yiming Qin, Zhouyu Guan, Tingli Chen, Yali Jia, Ping Zhang, Dian Zeng, Sayoko Moroi, Rajiv Raman, Benjamin Sommer Thinggaard, Frederik Pedersen, José Alogo Obiang Ñehe, Tengku Ain Kamalden, Yukun Zhou, Yixiao Jin, Huating Li, An Ran Ran, Dawei Yang, Ziyao Meng, Qingsheng Peng, Ying Feng Zheng, Dingqiao Wang, Hongwei Ji, Pengxiao Zang, Changchang Yin, Jie Shen, Youxin Chen, Weihong Yu, Rongping Dai, Chenxi Zhang, Xinyu Zhao, Xiangning Wang, Yan Chen, Qiang Wu, Hongbin Xie, Simon K. H. Szeto, Julia Y. Y. Chan, Victor T. T. Chan, Hua-Tao Xie, Ruili Wei, Jin Li, Weizhi Ma, Lei Zhu, Hongqiu Wang, Huazhu Fu, Wenxiao Wang, Shan Lin, Zejun Xu, Nian Guan, Xiao Zhang, Andrzej Grzybowski, Monika Gołębiowska-Bogaj, Maciej Gawęcki, Adrian Smedowski, Wojciech Szaraniec, You Wu, Yang Wen, Xiang Chen, Yuanqi Yao, Lee-Ling Lim, Carol Y. Cheung, Gavin Siew Wei Tan, Jakob Grauslund, Paisan Ruamviboonsuk, Sobha Sivaprasad, Pearse A. Keane, Ya Xing Wang, Yih-Chung Tham, Ching-Yu Cheng, Tien Yin Wong, Bin Sheng","doi":"10.1038/s41591-025-03900-7","DOIUrl":null,"url":null,"abstract":"<p>In the context of an increasing need for clinical assessments of foundation models, we developed EyeFM, a multimodal vision–language eyecare copilot, and conducted a multifaceted evaluation, including retrospective validations, multicountry efficacy validation as a clinical copilot and a double-masked randomized controlled trial (RCT). EyeFM was pretrained on 14.5 million ocular images from five imaging modalities paired with clinical texts from global, multiethnic datasets. Efficacy validation invited 44 ophthalmologists across North America, Europe, Asia and Africa in primary and specialty care settings, highlighting its utility as a clinical copilot. The RCT—a parallel, single-center, double-masked study—assessed EyeFM as a clinical copilot in retinal disease screening among a high-risk population in China. A total of 668 participants (mean age 57.5 years, 79.5% male) were randomized to 16 ophthalmologists, equally allocated into intervention (with EyeFM copilot) and control (standard care) groups. The primary endpoint indicated that ophthalmologists with EyeFM copilot achieved higher correct diagnostic rate (92.2% versus 75.4%, <i>P</i> &lt; 0.001) and referral rate (92.2% versus 80.5%, <i>P</i> &lt; 0.001). Secondary outcome indicated improved standardization score of clinical reports (median 33 versus 37, <i>P</i> &lt; 0.001). Participant satisfaction with the screening was similar between groups, whereas the intervention group demonstrated higher compliance with self-management (70.1% versus 49.1%, <i>P</i> &lt; 0.001) and referral suggestions (33.7% versus 20.2%, <i>P</i> &lt; 0.001) at follow-up. Post-deployment evaluations indicated strong user acceptance. Our study provided evidence that implementing EyeFM copilot can improve the performance of ophthalmologists and the outcome of patients. Chinese Clinical Trial Registry registration: ChiCTR2500095518.</p>","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":"23 1","pages":""},"PeriodicalIF":50.0000,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41591-025-03900-7","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In the context of an increasing need for clinical assessments of foundation models, we developed EyeFM, a multimodal vision–language eyecare copilot, and conducted a multifaceted evaluation, including retrospective validations, multicountry efficacy validation as a clinical copilot and a double-masked randomized controlled trial (RCT). EyeFM was pretrained on 14.5 million ocular images from five imaging modalities paired with clinical texts from global, multiethnic datasets. Efficacy validation invited 44 ophthalmologists across North America, Europe, Asia and Africa in primary and specialty care settings, highlighting its utility as a clinical copilot. The RCT—a parallel, single-center, double-masked study—assessed EyeFM as a clinical copilot in retinal disease screening among a high-risk population in China. A total of 668 participants (mean age 57.5 years, 79.5% male) were randomized to 16 ophthalmologists, equally allocated into intervention (with EyeFM copilot) and control (standard care) groups. The primary endpoint indicated that ophthalmologists with EyeFM copilot achieved higher correct diagnostic rate (92.2% versus 75.4%, P < 0.001) and referral rate (92.2% versus 80.5%, P < 0.001). Secondary outcome indicated improved standardization score of clinical reports (median 33 versus 37, P < 0.001). Participant satisfaction with the screening was similar between groups, whereas the intervention group demonstrated higher compliance with self-management (70.1% versus 49.1%, P < 0.001) and referral suggestions (33.7% versus 20.2%, P < 0.001) at follow-up. Post-deployment evaluations indicated strong user acceptance. Our study provided evidence that implementing EyeFM copilot can improve the performance of ophthalmologists and the outcome of patients. Chinese Clinical Trial Registry registration: ChiCTR2500095518.

Abstract Image

眼保健基金会的临床援助模型:随机对照试验
在对基础模型的临床评估需求日益增加的背景下,我们开发了EyeFM,一个多模态视觉语言眼保健副驾驶,并进行了多方面的评估,包括回顾性验证,多国疗效验证作为临床副驾驶和双盲随机对照试验(RCT)。EyeFM在来自五种成像模式的1450万张眼部图像上进行了预训练,这些图像与来自全球多民族数据集的临床文本配对。疗效验证邀请了来自北美、欧洲、亚洲和非洲初级和专科护理机构的44名眼科医生,突出了其作为临床副试点的效用。这项平行、单中心、双盲的随机对照试验评估了EyeFM作为中国高风险人群视网膜疾病筛查的临床辅助试验。共有668名参与者(平均年龄57.5岁,男性79.5%)被随机分配到16名眼科医生中,平均分配到干预组(使用EyeFM副驾驶)和对照组(标准护理)。主要终点显示,使用EyeFM副驾驶的眼科医生的正确诊断率(92.2%比75.4%,P < 0.001)和转诊率(92.2%比80.5%,P < 0.001)更高。次要结局显示临床报告的标准化评分提高(中位数33比37,P < 0.001)。参与者对筛查的满意度在两组之间相似,而干预组在随访中表现出更高的自我管理依从性(70.1%对49.1%,P < 0.001)和转诊建议(33.7%对20.2%,P < 0.001)。部署后评估表明用户接受度很高。我们的研究提供了证据,证明实施EyeFM副驾驶可以提高眼科医生的工作效率和患者的预后。中国临床试验注册中心注册:ChiCTR2500095518。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nature Medicine
Nature Medicine 医学-生化与分子生物学
CiteScore
100.90
自引率
0.70%
发文量
525
审稿时长
1 months
期刊介绍: Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信